| Breakdown | TTM | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 | Feb 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 99.75B | 84.16B | 82.84B | 68.09B | 56.95B | 61.37B |
| Gross Profit | 26.19B | 20.77B | 15.68B | 13.52B | 9.88B | 10.67B |
| EBITDA | 33.34B | 30.23B | 25.53B | 22.09B | 17.89B | 15.14B |
| Net Income | 16.82B | 15.19B | 12.11B | 9.41B | 6.47B | 5.03B |
Balance Sheet | ||||||
| Total Assets | 444.05B | 406.71B | 367.01B | 338.62B | 337.89B | 347.08B |
| Cash, Cash Equivalents and Short-Term Investments | 51.63B | 42.69B | 46.92B | 40.58B | 46.46B | 51.42B |
| Total Debt | 298.18B | 262.11B | 232.79B | 209.96B | 209.40B | 220.00B |
| Total Liabilities | 318.40B | 284.00B | 250.74B | 224.23B | 225.70B | 236.82B |
| Stockholders Equity | 114.50B | 111.71B | 105.51B | 103.84B | 101.78B | 100.06B |
Cash Flow | ||||||
| Free Cash Flow | -42.28B | -33.50B | -18.01B | -13.44B | 862.00M | -1.33B |
| Operating Cash Flow | -31.85B | -28.45B | -9.81B | -2.92B | 6.66B | 15.12B |
| Investing Cash Flow | -112.00M | 5.36B | -1.29B | 5.81B | 7.78B | -5.29B |
| Financing Cash Flow | 30.19B | 19.57B | 17.79B | -6.58B | -15.36B | 167.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥130.22B | 20.19 | 15.81% | 2.93% | 84.20% | 137.87% | |
73 Outperform | ¥4.32T | 16.16 | 9.64% | 0.97% | 0.49% | 12.19% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
65 Neutral | ¥779.51B | 6.28 | 10.59% | 2.94% | -19.09% | 16.31% | |
63 Neutral | ¥207.06B | 21.96 | 16.39% | 2.38% | 7.21% | 112.45% | |
62 Neutral | ¥69.78B | 8.53 | ― | 2.89% | -3.09% | -35.66% | |
57 Neutral | ¥955.68B | 17.83 | 7.40% | 3.68% | 3.52% | -17.58% |